Nevada Senate Committee Hears Testimony on Resolution Declaring Antimicrobial Resistance a Public Health Crisis

At a meeting in Carson City, the Nevada Senate Committee on Commerce and Labor heard testimony on Senate Concurrent Resolution 5, which recognizes antimicrobial resistance (AMR) as a public health crisis and urges public-health actions to slow the spread of resistant infections.

Esmeralda Vasquez, a representative of the diagnostics company bioMérieux, told the committee that the resolution seeks to prompt “smarter use of rapid diagnostics, stronger public education around antibiotic use, and partnerships between public and private stakeholders.” Vasquez said the Centers for Disease Control and Prevention estimates 35,000 Americans die each year from resistant infections and said Nevada has seen infections increase from 32 percent to over 36 percent in a single year.

The resolution does not itself change state law or Medicaid policy; it is a statement encouraging agencies and stakeholders to take steps to address AMR. Vasquez said the resolution “asks our public health care agencies to take smart proactive steps” and urged lawmakers to support SCR 5.

Committee members asked questions about the scope of AMR and about possible conflicts of interest. Senator Ellison asked, "Is this disease or, or be honest, call it it is it go to pulmonary? Is it is it lung disease?" Vasquez replied that AMR can affect different types of bacteria and body sites and that the pattern depends on the specific organism, citing regional antibiograms maintained by the Northern Nevada and Southern Nevada public health districts. She said she could provide more specific information to the committee.

Senator Scheibel asked whether the presenting company would financially benefit from policies the resolution encourages, noting the common concern that resolutions or policy changes brought on behalf of an industry could confer commercial advantage. Scheibel asked, "If the policy were to change at the national level like you're requesting, would your company financially benefit from it?" Vasquez said, "I do not know the answer to that, but I can get back to you."

Chair Pizzino (listed in the roll call) and other committee members did not cast a recorded vote on the resolution during the session. The chair asked the presenter to provide answers to the committee’s outstanding questions "at your earliest convenience" because the legislative session is approaching deadlines. The committee then moved to public comment; no callers or in-person commenters appeared on SCR 5, and the meeting concluded without a formal committee action recorded on the resolution.

Why it matters: Public-health experts view antimicrobial resistance as a mounting challenge because resistant infections can lengthen hospital stays, increase costs and raise mortality. SCR 5 would encourage Nevada agencies and payors to promote diagnostics and stewardship practices and to consider outreach to low-income communities, which the presenter noted may face higher risk and fewer resources.

The committee requested follow-up information from the presenter on technical points and on whether the company would derive financial benefit from policy changes. Those materials were requested before the resolution proceeds further in the legislative process.